Nonsense-mediated MRNA Decay Inhibition Synergizes with MDM2 Inhibition to Suppress TP53 Wild-type Cancer Cells in P53 Isoform-dependent Manner
Overview
Authors
Affiliations
The restoration of the normal function of the tumour suppressors, such as p53, is an important strategy in tumour therapeutics. Nonsense-mediated mRNA decay (NMD) inhibition by NMD inhibitor (NMDi) upregulates functional p53 isoforms, p53β and p53γ, and activates the p53 pathway. XR-2, a novel mouse double minute 2 homolog (MDM2) inhibitor, can disrupt the interaction between p53 and MDM2, thus decreasing the MDM2-mediated degradation of p53 and increasing the p53 protein levels. However, the combined effects of these two agents have not been thoroughly explored. This study combined XR-2 and NMDi in four TP53 wild-types and four TP53-mutated cancer cell lines. The combination of these two agents achieved significant synergistic effects on TP53 wild-type cancer cell lines by transactivating p53 target genes, inducing apoptosis, cell-cycle arrest and DNA damage repair. The p53β isoform induced by NMDi enhances the transactivation ability of p53α induced by XR-2, which partially explains the mechanism of the synergistic effects of XR-2 and NMDi. This study identified a combination treatment of NMDi and XR-2 which could serve as a novel cancer therapeutic approach for MDM2-overexpressed TP53 wild-type cancers and delineated a future therapy based on the further reactivation of p53.
Re-appraising the evidence for the source, regulation and function of p53-family isoforms.
Lopez I, Valdivia I, Vojtesek B, Fahraeus R, Coates P Nucleic Acids Res. 2024; 52(20):12112-12129.
PMID: 39404067 PMC: 11551734. DOI: 10.1093/nar/gkae855.
Yu S, Si Y, Yu J, Jiang C, Cheng F, Xu M Cancer Sci. 2024; 115(12):3915-3927.
PMID: 39329452 PMC: 11611762. DOI: 10.1111/cas.16356.
Parodis I, Lindblom J, Barturen G, Ortega-Castro R, Cervera R, Pers J Ann Rheum Dis. 2024; 83(7):889-900.
PMID: 38373843 PMC: 11187369. DOI: 10.1136/ard-2023-224795.
Synthesis and Antineoplastic Activity of a Dimer, Spiroindolinone Pyrrolidinecarboxamide.
Cui J, Wang Y, Li X, Xiao F, Ren H, Wu M Molecules. 2023; 28(9).
PMID: 37175323 PMC: 10180320. DOI: 10.3390/molecules28093912.
High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Wang X, Li W, Lou N, Han W, Hai B, Xiao W Pharmgenomics Pers Med. 2023; 16:1-14.
PMID: 36636625 PMC: 9831534. DOI: 10.2147/PGPM.S382843.